Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 186

1.

Impact of statin dosing intensity on transaminase and creatine kinase.

Dale KM, White CM, Henyan NN, Kluger J, Coleman CI.

Am J Med. 2007 Aug;120(8):706-12.

PMID:
17679130
2.
3.

Impact of gender on statin efficacy.

Dale KM, Coleman CI, Shah SA, Patel AA, Kluger J, White CM.

Curr Med Res Opin. 2007 Mar;23(3):565-74. Review.

PMID:
17355737
4.

Meta-analysis of drug-induced adverse events associated with intensive-dose statin therapy.

Silva M, Matthews ML, Jarvis C, Nolan NM, Belliveau P, Malloy M, Gandhi P.

Clin Ther. 2007 Feb;29(2):253-60.

PMID:
17472818
5.

Risks associated with statin therapy: a systematic overview of randomized clinical trials.

Kashani A, Phillips CO, Foody JM, Wang Y, Mangalmurti S, Ko DT, Krumholz HM.

Circulation. 2006 Dec 19;114(25):2788-97. Epub 2006 Dec 11. Review.

6.

Primary prevention of cardiovascular mortality and events with statin treatments: a network meta-analysis involving more than 65,000 patients.

Mills EJ, Rachlis B, Wu P, Devereaux PJ, Arora P, Perri D.

J Am Coll Cardiol. 2008 Nov 25;52(22):1769-81. doi: 10.1016/j.jacc.2008.08.039.

8.

The risk for significant creatine kinase elevation with statins.

Stolcpart RS, Olson KL, Delate T, Rasmussen J, Rehring TF, Merenich JA.

Am J Cardiovasc Drugs. 2010;10(3):187-92. doi: 10.2165/11536130-000000000-00000.

PMID:
20524720
9.

Impact of statins on risk of stroke: a meta-analysis.

Henyan NN, Riche DM, East HE, Gann PN.

Ann Pharmacother. 2007 Dec;41(12):1937-45. Epub 2007 Nov 6.

PMID:
17986516
10.

Statins, fibrates, and melanoma risk: a systematic review and meta-analysis.

Freeman SR, Drake AL, Heilig LF, Graber M, McNealy K, Schilling LM, Dellavalle RP.

J Natl Cancer Inst. 2006 Nov 1;98(21):1538-46. Review.

PMID:
17077356
11.

Impact of systemic hypertension on the cardiovascular benefits of statin therapy--a meta-analysis.

Messerli FH, Pinto L, Tang SS, Thakker KM, Cappelleri JC, Sichrovsky T, Dubois RW.

Am J Cardiol. 2008 Feb 1;101(3):319-25. doi: 10.1016/j.amjcard.2007.08.033.

PMID:
18237593
12.

Benefits and risks of adjunctive inhaled corticosteroids in chronic obstructive pulmonary disease: a meta-analysis.

Sobieraj DM, White CM, Coleman CI.

Clin Ther. 2008 Aug;30(8):1416-25. doi: 10.1016/j.clinthera.2008.08.004.

PMID:
18803985
13.

Statin-related adverse events: a meta-analysis.

Silva MA, Swanson AC, Gandhi PJ, Tataronis GR.

Clin Ther. 2006 Jan;28(1):26-35.

PMID:
16490577
14.

Should high creatine kinase discourage the initiation or continuance of statins for the treatment of hypercholesterolemia?

Glueck CJ, Rawal B, Khan NA, Yeramaneni S, Goldenberg N, Wang P.

Metabolism. 2009 Feb;58(2):233-8. doi: 10.1016/j.metabol.2008.09.019.

PMID:
19154957
15.

Statin therapy in stroke prevention: a meta-analysis involving 121,000 patients.

O'Regan C, Wu P, Arora P, Perri D, Mills EJ.

Am J Med. 2008 Jan;121(1):24-33. doi: 10.1016/j.amjmed.2007.06.033. Review.

PMID:
18187070
16.

The effect of statins on the development of new-onset type 2 diabetes: a meta-analysis of randomized controlled trials.

Coleman CI, Reinhart K, Kluger J, White CM.

Curr Med Res Opin. 2008 May;24(5):1359-62. doi: 10.1185/030079908X292029 . Epub 2008 Apr 1. Review.

PMID:
18384710
17.

The efficacy and safety of intensive statin therapy: a meta-analysis of randomized trials.

Josan K, Majumdar SR, McAlister FA.

CMAJ. 2008 Feb 26;178(5):576-84. doi: 10.1503/cmaj.070675.

19.

Screening for statin-related toxicity: the yield of transaminase and creatine kinase measurements in a primary care setting.

Smith CC, Bernstein LI, Davis RB, Rind DM, Shmerling RH.

Arch Intern Med. 2003 Mar 24;163(6):688-92.

PMID:
12639201
20.

Supplemental Content

Support Center